Results

Total Results: 2,005 records

Showing results for "adverse".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - But SGAs also have potentially serious adverse effects (e.g., cardiovascular and endocrinologic adverse … Harms Outcomes: KQ 1: § Overall adverse events (frequency of any adverse events reported in trials … events (frequency of any adverse events reported in trials) § Withdrawals due to adverse events, … ) • Significant (major) adverse events KQ 2: • Overall adverse events (frequency of any adverse events … reported in trials) • Withdrawals due to adverse events, time to withdrawal due to adverse events
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
    October 29, 2012 - events: 1 serious adverse events: The [(n/N (%)] was 6/127 (5) versus 4/120 (3); p= 0.70 Any adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events: … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse … events [(n/N (%)] 1 serious adverse events: 6/127 (5) vs. 4/120 (3); p= 0.70 Any adverse events … Fesoterodine resulted in higher rates of adverse effects and discontinuation of treatment due to adverse
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
    March 08, 2012 - Adverse local effects may include nosebleeds, stinging, burning, and dryness. … Other local adverse effects may include nosebleeds, stinging, burning, and dryness. … Local adverse effects may include nosebleeds and nasal and oral dryness. … How do adverse effects vary with intermittent or continuous use? … Table 4 lists systemic and local adverse effects of interest.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes). … Data were insufficient for adverse events. 18 Table D. … for adverse events (not for VTE outcomes). … for adverse events (not for VTE outcomes).
  6. Insomnia Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
    December 01, 2015 - Evidence on adverse effects was insufficient. … Adverse effects did not differ between groups. … Data were insufficient for adverse effects. … Withdrawals due to adverse effects, but not any specific adverse effect or overall withdrawals, were … long-term use or rare adverse effects.
  7. effectivehealthcare-admin.ahrq.gov/products/safety-emerging-methods/overview
    November 01, 2017 - Developing Indicators of Inpatient Adverse Drug Events Through Nonlinear Analysis Using Administrative … Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events Tracy A. … Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events. … Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug … Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
    April 01, 2013 - To assess adverse effects and treatment discontinuation due to adverse effects, we analyzed all included … Adverse Effects With Drugs for Chronic Migraine Onabotulinumtoxin A resulted in adverse effects and … Increase in risk of adverse effects was dose responsive. … Adverse Effects With Drugs for Episodic Migraine Bothersome adverse effects leading to treatment discontinuation … in trials with higher placebo rates of adverse effects.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - informative - There is new evidence available for KQ1 (effectiveness, health outcomes) and KQ3 (adverse … , bone density, and cosmetic adverse effects? … Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. … , bone density, and cosmetic adverse effects? … , bone density, and cosmetic adverse effects?
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - mellitus, what is the comparative safety of the following treatment options in terms of the following adverse … addition to updating information on the potential benefits of available treatments, conclusions regarding adverse … There have been a number of potential adverse events associated with rosiglitazone (e.g. increased
  12. effectivehealthcare-admin.ahrq.gov/products/glucocorticoid-injections/clinician
    November 01, 2017 - Key Clinical Issue What are the relative effectiveness and adverse effects of epidural injections of … This trial also sought to compare the adverse effects of epidural injections of glucocorticoids plus … The most common adverse events were fever/infection and headache in the glucocorticoidsplus-lidocaine … Serious adverse events (hospitalization or surgery) were rare among all patients. … Furthermore, the potential adverse effects of systemic glucocorticoids (e.g., elevated blood glucose,
  13. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - due to any adverse event did not reach statistical significance). … , any GI adverse events (RR 0.31, 95% CI 0.24 to 0.39), and withdrawals due to GI adverse events (RR … , 95% CI 0.70 to 0.99), but there was no difference in risk of GI adverse events, withdrawal due to adverse … events, or withdrawal due to GI adverse events. … events and higher risk of dermatologic adverse compared to oral NSAIDs.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo. … for at least 28 weeks. 78.2% had at least one adverse event (AE), but only 4.6% had a No safety … Common adverse events include: nausea/ vomiting, respiratory infection, abdominal pain, abnormal … ACR50 response rates were Did not conduct statistical tests on adverse events data. … Overall adverse event profiles appeared to be similar for biologic DMARDs and placebo.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - • BT causes more adverse events (such as worsening of asthma symptoms, respiratory infections, and … • Patients treated with BT developed the following common adverse events: bronchial irritation, chest … Serious adverse events occurred more frequently in BT-treated patients than in patients receiving sham … Serious adverse events attributed to BT were infrequent, and no deaths were reported. … The risk of adverse events is higher early in treatment, while benefit is typically observed weeks to
  16. effectivehealthcare-admin.ahrq.gov/products/hip-fracture-pain/research
    December 01, 2019 - participate in rehabilitation, return to pre-fracture living arrangements, health services utilization, and adverse … and postoperative pain management, albeit from few perspectives such as reported pain, mortality, and adverse … Although most studies reported on adverse effects, they were short term and not adequately powered to
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
    September 01, 2014 - • What factors associated with the patient and her breast abnormality influence the adverse events of … Studies included for the assessment of possible adverse events of core needle biopsy (Key Question 2 … Core needle biopsy was only infrequently associated with serious adverse events. … adverse events) compared to core needle biopsy. … Our assessment of the strength of evidence for adverse events is summarized in Table H.
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
    December 14, 2010 - (i.e. staple-line disruption or ulcer), nutritional deficiencies - LAGB-specific adverse events: … • Adverse events: o Short-term: - mortality - systemic medical complications (i.e. myocardial … KQ3: What are the potential short term adverse effects and/or complications involved with bariatric … Outcome measures for harms, or adverse events, are the same as in KQ3, and KQ5 below. … adverse events  Adverse reactions to medications Figure 1.
  19. S5 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - to structure both interventional and database-oriented studies, particu- larly those concerned with adverse … and state hospital data—for examining initi- ation, persistence, and adherence, and the benefits and adverse … events.13 The National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance … Real-time vaccine safety surveillance for the early detection of adverse events. … A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - Our work will expand the consensus report Adverse Effects of Vaccines: Evidence and Causality, which … (CTCAE) classification system, and serious adverse events (SAE) will be defined and coded. … The absolute risk of serious adverse events (SAEs) will also be computed. … event CTCAE = Common Terminology Criteria for Adverse Events Hib = Haemophilus influenzae type b … Adverse events of interest, included in electronic search terms Adverse event Vaccine type Acute

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: